Related Experiment Video
Updated: Jul 28, 2026
11:08
The Use of Gas Chromatography to Analyze Compositional Changes of Fatty Acids in Rat Liver Tissue during Pregnancy
Published on: March 13, 2014
Pregnancy-Related Liver Diseases.
1Gastroenterology Division, University of Michigan Medical Center, 6520 MSRB-I, 1150 Medical Center Drive, Ann Arbor, MI 48109-0682, USA. wynne@umich.edu
Current Treatment Options in Gastroenterology
|November 30, 2000
Summary
Pregnancy-specific liver diseases are unique and resolve post-delivery. Differentiating these from other liver conditions during pregnancy is crucial for accurate diagnosis and management.
Area of Science:
- Hepatology
- Obstetrics
- Maternal-Fetal Medicine
Background:
- Pregnancy is associated with unique physiological changes affecting liver function.
- Several liver diseases manifest with increased frequency during gestation.
- Distinguishing pregnancy-specific liver conditions from incidental hepatopathies is clinically significant.
Purpose of the Study:
- To delineate the spectrum of liver diseases unique to pregnancy.
- To emphasize the importance of differentiating gestational hepatitides from coincident liver diseases.
- To provide a framework for accurate diagnosis in pregnant patients with liver abnormalities.
Main Methods:
- Review of existing literature on pregnancy-related liver diseases.
- Clinical case analysis of patients presenting with liver dysfunction during pregnancy.
- Comparative analysis of diagnostic criteria for gestational vs. incidental liver diseases.
Main Results:
- Identification of four distinct liver diseases exclusive to pregnancy, resolving postpartum.
- Recognition of common liver conditions with altered prevalence in pregnant individuals.
- Highlighting overlapping clinical and biochemical features necessitating careful differential diagnosis.
Conclusions:
- Accurate differentiation of pregnancy-specific liver diseases is essential for appropriate management.
- Timely diagnosis prevents unnecessary interventions and ensures optimal maternal and fetal outcomes.
- Understanding these distinctions is critical for healthcare providers managing pregnant patients.
More Related Videos
Related Concept Videos
01:07Teratogenicity
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
01:26Diseases of the Liver and Gallbladder
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:23Cirrhosis I: Introduction
Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
01:24Cirrhosis II: Pathophysiology
Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...